Post Categories
Blog post not found!
New AstraZeneca Drug for HER2-Low Breast Cancer Aces Phase III Trial
Infographics Not all cancer cases are created equal. As the medical community hones in on better, less invasive cancer treatments, differentiating between different types…

New AstraZeneca Drug for HER2-Low Breast Cancer Aces Phase III Trial
March 9, 2022
Infographics Not all cancer cases are created equal. As the medical community hones in on better, less invasive cancer treatments, differentiating between different types…
Superbugs Emerging as Super-Big Problem, Demand Urgent Attention
Results of a comprehensive global study of antimicrobial resistance (AMR) show that infections caused by antibiotic-resistant bacteria — also known as “superbugs” — were…

Superbugs Emerging as Super-Big Problem, Demand Urgent Attention
March 7, 2022
Results of a comprehensive global study of antimicrobial resistance (AMR) show that infections caused by antibiotic-resistant bacteria — also known as “superbugs” — were…
Longhorn Beetles, 200-Year-Old Fish, and How Genetics Drive Genomic Diversity
The sternotomis callais beetle, otherwise known as the flat-faced longhorn beetle, resides in Central Africa. Rockfish, a species of fish known for their long…

Longhorn Beetles, 200-Year-Old Fish, and How Genetics Drive Genomic Diversity
March 2, 2022
The sternotomis callais beetle, otherwise known as the flat-faced longhorn beetle, resides in Central Africa. Rockfish, a species of fish known for their long…
Meet the Xenobots, Living Robots That Can Reproduce
“Life finds a way.” Those were the prophetic words of Dr. Ian Malcolm in Steven Spielberg’s blockbuster Jurassic Park. Now, as researchers discover that…

Meet the Xenobots, Living Robots That Can Reproduce
February 28, 2022
“Life finds a way.” Those were the prophetic words of Dr. Ian Malcolm in Steven Spielberg’s blockbuster Jurassic Park. Now, as researchers discover that…
Cancer Cure? 10-Year Leukemia Remission Reported with Personalized T-Cell Therapy
Research results published in Nature this month demonstrate that chimeric antigen receptor (CAR) T-cell therapy, which uses engineered T-cells to target cancer, held leukemia…

Cancer Cure? 10-Year Leukemia Remission Reported with Personalized T-Cell Therapy
February 21, 2022
Research results published in Nature this month demonstrate that chimeric antigen receptor (CAR) T-cell therapy, which uses engineered T-cells to target cancer, held leukemia…
Groundbreaking Pig Heart Transplant Saves Patient’s Life
Xenotransplantation, or the transplantation of non-human tissues or organs into a human recipient, has long been a controversial possibility in the medical field. After…

Groundbreaking Pig Heart Transplant Saves Patient’s Life
February 16, 2022
Xenotransplantation, or the transplantation of non-human tissues or organs into a human recipient, has long been a controversial possibility in the medical field. After…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…